1-15 of 15
azacitidine
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In MDS, is higher risk higher reward?

Guillermo F. Sanz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 381–390.
https://doi.org/10.1182/hematology.2019000042
Published: 2019
Journal Articles

Incorporating novel approaches in the management of MDS beyond conventional hypomethylating agents

Olatoyosi Odenike
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 460–469.
https://doi.org/10.1182/asheducation-2017.1.460
Published: 2017
Journal Articles

Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure

Hetty E. Carraway
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 470–477.
https://doi.org/10.1182/asheducation-2016.1.470
Published: 2016
Journal Articles

Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse?

Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 308–316.
https://doi.org/10.1182/asheducation-2015.1.308
Published: 2015
Journal Articles

Treating acute myeloid leukemia in older adults

Eunice S. Wang
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 14–20.
https://doi.org/10.1182/asheducation-2014.1.14
Published: 2014
Journal Articles

Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes

Yogen Saunthararajah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 511–521.
https://doi.org/10.1182/asheducation-2013.1.511
Published: 2013
Journal Articles

Santini V. Novel therapeutic strategies: hypomethylating agents and beyond. Hematology Am Soc Hematol Educ Program. 2012;2012: 65–73 .

Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 692.
https://doi.org/10.1182/asheducation.V2013.1.692.3851497a
Published: 2013
Journal Articles

Novel therapeutic strategies: hypomethylating agents and beyond

Valeria Santini
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 65–73.
https://doi.org/10.1182/asheducation.V2012.1.65.3806843
Published: 2012
Journal Articles

New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome

Steven D. Gore
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 550–555.
https://doi.org/10.1182/asheducation-2011.1.550
Published: 2011
Journal Articles

How Much? How Frequent? How Long? A Clinical Guide to New Therapies in Myelodysplastic Syndromes

William Blum
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 314–321.
https://doi.org/10.1182/asheducation-2010.1.314
Published: 2010
Journal Articles

Treatment of MDS: something old, something new, something borrowed…

Mikkael A. Sekeres
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 656–663.
https://doi.org/10.1182/asheducation-2009.1.656
Published: 2009
Journal Articles

Clinical Issues in the Management of Patients with Myelodysplasia

Charles A. Schiffer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 205–210.
https://doi.org/10.1182/asheducation-2006.1.205
Published: 2006
Journal Articles

Update on Supportive Care and New Therapies: Immunomodulatory Drugs, Growth Factors and Epigenetic-Acting Agents

Eva Hellström-Lindberg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 161–166.
https://doi.org/10.1182/asheducation-2005.1.161
Published: 2005
Journal Articles

Myelodysplastic Syndrome

Ghulam Mufti, Alan F. List, Steven D. Gore, Aloysius Y.L. Ho
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 176–199.
https://doi.org/10.1182/asheducation-2003.1.176
Published: 2003
Journal Articles

Achievements in Understanding and Treatment of Myelodysplastic Syndromes

Eva Hellström-Lindberg, Cheryl Willman, A. John Barrett, Yogen Saunthararajah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 110–132.
https://doi.org/10.1182/asheducation.V2000.1.110.110
Published: 2000